$MDRX
Veradigm Inc.

2017 Q3 Form 10-Q Financial Statement

#000156459017023001 Filed on November 09, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2016 Q3
Revenue $449.4M $392.4M
YoY Change 14.54% 10.69%
Cost Of Revenue $205.8M $226.2M
YoY Change -9.01% 12.48%
Gross Profit $162.2M $166.2M
YoY Change -2.35% 8.35%
Gross Profit Margin 36.1% 42.35%
Selling, General & Admin $93.79M $98.78M
YoY Change -5.05% 8.5%
% of Gross Profit 57.81% 59.45%
Research & Development $46.49M $45.14M
YoY Change 2.98% -5.37%
% of Gross Profit 28.65% 27.17%
Depreciation & Amortization $53.80M $43.90M
YoY Change 22.55% 7.07%
% of Gross Profit 33.16% 26.42%
Operating Expenses $140.3M $143.9M
YoY Change -2.53% 3.73%
Operating Profit $18.16M $16.87M
YoY Change 7.6% 90.26%
Interest Expense $9.251M $19.37M
YoY Change -52.23% -306.03%
% of Operating Profit 50.95% 114.77%
Other Income/Expense, Net -$685.0K -$6.000K
YoY Change 11316.67% -101.42%
Pretax Income -$12.03M -$2.499M
YoY Change 381.39% 73.42%
Income Tax $1.962M -$2.656M
% Of Pretax Income
Net Earnings -$17.46M -$10.19M
YoY Change 71.45% 94.22%
Net Earnings / Revenue -3.89% -2.6%
Basic Earnings Per Share -$0.16 -$0.06
Diluted Earnings Per Share -$0.16 -$0.06
COMMON SHARES
Basic Shares Outstanding 180.6M 186.2M
Diluted Shares Outstanding 180.6M 186.2M

Balance Sheet

Concept 2017 Q3 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $104.3M $77.30M
YoY Change 34.93% -15.43%
Cash & Equivalents $104.3M $76.64M
Short-Term Investments
Other Short-Term Assets $120.8M $112.4M
YoY Change 7.47% -16.24%
Inventory
Prepaid Expenses
Receivables $442.9M $400.1M
Other Receivables $0.00 $0.00
Total Short-Term Assets $668.0M $589.8M
YoY Change 13.26% 7.19%
LONG-TERM ASSETS
Property, Plant & Equipment $165.4M $144.8M
YoY Change 14.22% 13.36%
Goodwill $1.882B
YoY Change 53.93%
Intangibles $79.00M $809.8M
YoY Change -90.24% 96.11%
Long-Term Investments $0.00 $2.436M
YoY Change -100.0%
Other Assets $153.7M $122.3M
YoY Change 25.68% -62.79%
Total Long-Term Assets $3.215B $3.220B
YoY Change -0.15% 51.68%
TOTAL ASSETS
Total Short-Term Assets $668.0M $589.8M
Total Long-Term Assets $3.215B $3.220B
Total Assets $3.883B $3.810B
YoY Change 1.92% 42.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $114.3M $93.24M
YoY Change 22.59% 38.35%
Accrued Expenses $141.9M $85.34M
YoY Change 66.28% 20.78%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $35.80M $12.05M
YoY Change 197.07% -5.11%
Total Short-Term Liabilities $684.4M $625.5M
YoY Change 9.42% 27.78%
LONG-TERM LIABILITIES
Long-Term Debt $1.381B $1.210B
YoY Change 14.13% 88.34%
Other Long-Term Liabilities $105.8M $71.10M
YoY Change 48.8% 11.98%
Total Long-Term Liabilities $1.487B $1.281B
YoY Change 16.05% 81.47%
TOTAL LIABILITIES
Total Short-Term Liabilities $684.4M $625.5M
Total Long-Term Liabilities $1.487B $1.281B
Total Liabilities $2.778B $2.481B
YoY Change 11.99% 94.13%
SHAREHOLDERS EQUITY
Retained Earnings -$190.2M
YoY Change -7.91%
Common Stock $1.793B
YoY Change 0.45%
Preferred Stock
YoY Change
Treasury Stock (at cost) $260.8M
YoY Change 37.46%
Treasury Stock Shares $82.78M
Shareholders Equity $1.105B $1.330B
YoY Change
Total Liabilities & Shareholders Equity $3.883B $3.810B
YoY Change 1.92% 42.53%

Cashflow Statement

Concept 2017 Q3 2016 Q3
OPERATING ACTIVITIES
Net Income -$17.46M -$10.19M
YoY Change 71.45% 94.22%
Depreciation, Depletion And Amortization $53.80M $43.90M
YoY Change 22.55% 7.07%
Cash From Operating Activities $63.80M $53.10M
YoY Change 20.15% 34.43%
INVESTING ACTIVITIES
Capital Expenditures -$50.70M -$41.30M
YoY Change 22.76% 164.74%
Acquisitions
YoY Change
Other Investing Activities -$54.20M -$29.70M
YoY Change 82.49% 29600.0%
Cash From Investing Activities -$104.9M -$71.10M
YoY Change 47.54% 350.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $19.00M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 61.10M 4.700M
YoY Change 1200.0% -158.02%
NET CHANGE
Cash From Operating Activities 63.80M 53.10M
Cash From Investing Activities -104.9M -71.10M
Cash From Financing Activities 61.10M 4.700M
Net Change In Cash 20.00M -13.30M
YoY Change -250.38% -185.26%
FREE CASH FLOW
Cash From Operating Activities $63.80M $53.10M
Capital Expenditures -$50.70M -$41.30M
Free Cash Flow $114.5M $94.40M
YoY Change 21.29% 71.32%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q3 mdrx Impairment Of And Loss On Long Term Investments
ImpairmentOfAndLossOnLongTermInvestments
20700000
CY2016Q3 mdrx Impairment Of And Loss On Long Term Investments
ImpairmentOfAndLossOnLongTermInvestments
0
mdrx Impairment Of And Loss On Long Term Investments
ImpairmentOfAndLossOnLongTermInvestments
165290000
mdrx Impairment Of And Loss On Long Term Investments
ImpairmentOfAndLossOnLongTermInvestments
0
us-gaap Impairment Of Investments
ImpairmentOfInvestments
165290000
us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3711000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2057000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
31256000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12723000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6939000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3381000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2908000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
26341000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-6196000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-8843000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
5930000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-12933000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
18661000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
30587000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
12894000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-28000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
173183000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
185158000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
40216000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25046000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
107079000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
69994000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
54308000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
935280000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
5423000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
20685000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-215000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-37000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-206811000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1050968000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
84000
us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
0
us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
333606000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
0
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
972000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6777000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7379000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
9013000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
3858000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
115281000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
80507000
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
189698000
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
654135000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
12077000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
71082000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
2398000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
0
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
1494000
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
45646000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
825971000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
796000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
217000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
12814000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-39622000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
96610000
CY2015Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
116873000
CY2017Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
109424000
CY2016Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
77251000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of consolidated financial statements in accordance with GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the consolidated financial statements and the accompanying notes. Actual results could differ materially from these estimates.</p></div>
mdrx Contribution And Investment Agreement Date Of Agreement
ContributionAndInvestmentAgreementDateOfAgreement
2016-03-20
CY2017Q3 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
271000
CY2016Q4 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
149542000
mdrx Number Of Equity Method Investments
NumberOfEquityMethodInvestments
3
mdrx Number Of Cost Method Investments
NumberOfCostMethodInvestments
7
mdrx Number Of Equity And Cost Method Investments
NumberOfEquityAndCostMethodInvestments
10
CY2017Q3 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
1658000
CY2017Q3 us-gaap Cost Method Investments Original Cost
CostMethodInvestmentsOriginalCost
32784000
CY2017Q3 mdrx Equity And Cost Method Investments Original Investment
EquityAndCostMethodInvestmentsOriginalInvestment
34442000
CY2016Q4 us-gaap Equity Method Investments
EquityMethodInvestments
2436000
CY2017Q3 us-gaap Cost Method Investments
CostMethodInvestments
26572000
CY2017Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
30714000
CY2016Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
28477000
CY2017Q2 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
142200000
CY2017Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
205600000
CY2017Q3 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-20700000
CY2017Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
CY2016Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10404000
CY2016Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9773000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
30391000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
30834000
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
49000
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
13.36
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
3131000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
12.50
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
1200000
CY2016 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
1500000
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
569000
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
572000
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
180634000
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
186226000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
180864000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
187190000
CY2017Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2016Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
180634000
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
186226000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
180864000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
187190000
CY2017Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
26085000
CY2016Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
27580000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
26636000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
26219000
CY2017Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1481576000
CY2017Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
843343000
CY2017Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
638233000
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1440840000
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
778437000
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
662403000
CY2017Q3 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
79000000
CY2016Q4 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
79000000
CY2017Q3 mdrx Indefinite Lived Intangible Assets Including Goodwill
IndefiniteLivedIntangibleAssetsIncludingGoodwill
2050950000
CY2016Q4 mdrx Indefinite Lived Intangible Assets Including Goodwill
IndefiniteLivedIntangibleAssetsIncludingGoodwill
2003052000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
32943000
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
9058000
us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
4955000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
942000
CY2017Q3 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0
CY2016Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0
CY2016Q1 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
400000
CY2017Q2 us-gaap Impairment Of Investments
ImpairmentOfInvestments
144600000
CY2017Q3 us-gaap Impairment Of Investments
ImpairmentOfInvestments
20700000
CY2017Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1462533000
CY2017Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
62280000
CY2017Q3 us-gaap Long Term Debt
LongTermDebt
1400253000
CY2016Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1386813000
CY2016Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
74433000
CY2016Q4 us-gaap Long Term Debt
LongTermDebt
1312380000
CY2017Q3 mdrx Debt Instrument Carrying Amount Current
DebtInstrumentCarryingAmountCurrent
25000000
CY2017Q3 mdrx Debt Instrument Unamortized Discount And Debt Issuance Costs Current
DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsCurrent
450000
CY2016Q4 mdrx Debt Instrument Carrying Amount Current
DebtInstrumentCarryingAmountCurrent
15638000
CY2016Q4 mdrx Debt Instrument Unamortized Discount And Debt Issuance Costs Current
DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsCurrent
480000
CY2017Q3 mdrx Debt Instrument Carrying Amount Noncurrent
DebtInstrumentCarryingAmountNoncurrent
1432667000
CY2017Q3 mdrx Debt Instrument Unamortized Discount And Debt Issuance Costs Non Current
DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNonCurrent
59713000
CY2017Q3 mdrx Long Term Debt And Non Recourse Long Term Debt Noncurrent
LongTermDebtAndNonRecourseLongTermDebtNoncurrent
1372954000
CY2016Q4 mdrx Debt Instrument Carrying Amount Noncurrent
DebtInstrumentCarryingAmountNoncurrent
1366824000
CY2016Q4 mdrx Debt Instrument Unamortized Discount And Debt Issuance Costs Non Current
DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNonCurrent
72053000
CY2016Q4 mdrx Long Term Debt And Non Recourse Long Term Debt Noncurrent
LongTermDebtAndNonRecourseLongTermDebtNoncurrent
1294771000
CY2017Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
7467000
CY2017Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
32991000
CY2017Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
45491000
CY2017Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
744866000
CY2017Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
4866000
CY2017Q3 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
626852000
CY2017Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.013
CY2016Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.063
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.006
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.060
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
64200000
mdrx Cumulative Operating Income Loss Period
CumulativeOperatingIncomeLossPeriod
P3Y
CY2017Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
12000000
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
11400000
CY2017Q3 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
46244000
CY2017Q3 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
45973000
CY2016Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
18101000
CY2016Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
17659000
CY2017Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-206000
CY2016Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-56000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-512000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
205000
CY2017Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0
CY2016Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0
CY2017Q3 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
271000
CY2016Q3 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-270000
CY2017Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
693000
CY2016Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
150000
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-126000
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-355000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3040000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-49000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
8
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76636000
CY2016Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
615000
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
11515000
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
0
us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
334000
us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
0

Files In Submission

Name View Source Status
0001564590-17-023001-index-headers.html Edgar Link pending
0001564590-17-023001-index.html Edgar Link pending
0001564590-17-023001.txt Edgar Link pending
0001564590-17-023001-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
mdrx-10q_20170930.htm Edgar Link pending
mdrx-20170930.xml Edgar Link completed
mdrx-20170930.xsd Edgar Link pending
mdrx-20170930_cal.xml Edgar Link unprocessable
mdrx-20170930_def.xml Edgar Link unprocessable
mdrx-20170930_lab.xml Edgar Link unprocessable
mdrx-20170930_pre.xml Edgar Link unprocessable
mdrx-ex23_161.htm Edgar Link pending
mdrx-ex311_32.htm Edgar Link pending
mdrx-ex312_31.htm Edgar Link pending
mdrx-ex321_30.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending